B

클래시스

214150KOSDAQ

59.0 / 100

Reference Date: 2026-10-23

Financial Score28.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 12.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Classys operates three main brands (CLASSYS, Cluederm, and ShringkRX/Skedum), focusing on aesthetic medical devices, consumables, and cosmetics. The company merged with IruDa in October 2024, enhancing its technological competitiveness in key EBD segments like micro-needle RF and laser. It generates revenue from over 80 countries, with medical devices and consumables accounting for 46% and 45% of sales, respectively.

Number of Employees

528people

Average Salary

65.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
13.83Industry Average 15.005.0Point

In line with industry avg

PBR
3.30Industry Average 1.200.0Point

2.8x industry avg (risky)

ROE
26.28Industry Average 8.007.0Point

3.3x industry avg (excellent)

Debt Ratio
13.19Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲36.8% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲38.0% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 27.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 27,900Won52-week high 75,60052-week low 26,600
1-month return1.0Point

1m -12.54% (falling)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral기업설명회(IR)개최2026-10-06
  • Neutral기업설명회(IR)개최2026-09-28